Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Chembio Diagnostics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Chembio Diagnostics Inc. market cap is $16.71M.
What is the 52-week high for Chembio Diagnostics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Chembio Diagnostics Inc. 52 week high is $1.24 as of September 08, 2025.
What is the 52-week low for Chembio Diagnostics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Chembio Diagnostics Inc. 52 week low is $0.19 as of September 08, 2025.
What is Chembio Diagnostics Inc. stock price today?
Chembio Diagnostics Inc. stock price today is $0.455.
What was Chembio Diagnostics Inc. stock price yesterday?
Chembio Diagnostics Inc. stock price yesterday was $0.454.
What is the PE ratio of Chembio Diagnostics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Chembio Diagnostics Inc.’s P/E ratio is -0.60.
What is the Price-to-Book ratio of Chembio Diagnostics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Chembio Diagnostics Inc. P/B ratio is 0.9399.
What is the 50-day moving average of Chembio Diagnostics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Chembio Diagnostics Inc. 50-day moving average is $0.4306.
